Modulight Biotherapeutics
United States
- Boston, Massachusetts
- 13/11/2025
- Seed
- $12,000,000
Modulight Biotherapeutics is developing a transformative optogenetic platform that precisely targets pathological neural activity when and where it occurs to restore balance in the nervous system.
- Industry Biotechnology Research
- Website https://www.modulight.bio/
- LinkedIn https://www.linkedin.com/company/modulight-bio/
Related People
Yotam EldarFounder
United States -
Boston, Massachusetts
Experienced leader of operational and technology teams, with a passion for solving complex multidisciplinary problems in a data-driven and results-oriented manner, to achieve a solid and positive impact in the world.
Long track record of excellence across several fields and industries - from leading complex special operations and projects, through medical practice, to biotech innovation.
Currently Yotam is focused on building a transformative solution for intractable neurological conditions, utilizing his deep technical understanding, creativity, leadership and networking skills to create a truly meaningful, positive change for patients.
Humand | $66,000,000 | (Feb 24, 2026)
Solid (AI for Data) | $20,000,000 | (Feb 24, 2026)
Comeryx | $7,500,000 | (Feb 24, 2026)
Maazah | $2,000,000 | (Feb 24, 2026)
Turgo.ai | $1,000,000 | (Feb 24, 2026)
Sherpas | $3,200,000 | (Feb 24, 2026)
Patientdesk.ai (YC W26) | $1,000,000 | (Feb 24, 2026)
Aalyria | $100,000,000 | (Feb 24, 2026)
Ubicquia, Inc | $106,000,000 | (Feb 24, 2026)
Freeform | $67,000,000 | (Feb 24, 2026)
Coral Care | $13,000,000 | (Feb 24, 2026)
Reload | $2,275,000 | (Feb 24, 2026)